Tag Archives: Drugs

gI_97286_andrew-white5

Two Soldiers Prescribed 54 Drugs: Military Mental Health “Treatment” Becomes Frankenpharmacy


Los Angeles, California (PRWEB) October 31, 2012

By Kelly Patricia O’Meara, for the Citizens Commission on Human Rights (CCHR)

“The devastating adverse effects mind-altering psychiatric drugs may be having on the nation’s military troops are best summed up by Mary Shelley’s Dr. Frankenstein, writing ‘nothing is so painful to the human mind as a great and sudden change.’

“Just as the fictional character, Dr. Frankenstein, turned to experiments in the laboratory to create life with fantastically horrific results, the psychiatric community, along with its pharmaceutical sidekicks, has turned to modern day chemical concoctions to alter the human mind. The result is what many believe is a growing number of equally hideous results culminating in senseless deaths, tormented lives and grief-stricken families.

“The nation’s military troops are taking their lives at record numbers and seemingly healthy soldiers are dying from sudden unexplained deaths. That’s a fact. The data are clear, yet, despite growing evidence pointing to the enemy among us, the monstrous psycho-pharmacological experiment continues.”

In the second installment of a four-part series, O’Meara examines the sudden unexplained deaths within the military tied to psychiatric drug use, including two soldiers who between them, were prescribed a whopping 54 drugs including Seroquel, Effexor, Paxil, Prozac, Remeron, Wellbutrin, Xanax, Zoloft, Ativan, Celexa, Cymbalta, Depakote, Haldol, Klonopin, Lexapro, Lithium, Lunesta, Compazine, Desyrel, Trileptal and Valium.


Marine corporal Andrew White, was a healthy 23-year-old, gung-ho Marine returning from a nine-month tour in Iraq, who, like so many of his brothers in arms, suffered from the seemingly normal stresses of war – insomnia, nightmares and restlessness. The young corporal turned to the military’s mental health system for help. But eleven months after beginning his first cocktail of mind-altering psychiatric drugs, he died in his sleep from what the medical examiner ruled an “accidental overdose of medication.” Since taking his first multi-drug cocktail to the date of his death, White had been prescribed no less than nineteen different drugs with many at ever-increasing dosages.

Twenty-three -year old Anthony (Tony) Mena had completed two tours in Iraq as part of Kirtland Air Force Base’s 377th Security Forces Squadron. Like so many others returning from combat, Mena suffered from insomnia, restlessness and nightmares—and like Andrew White, became a victim of the military’s mental health mind-altering multi-drug approach to treatment. Between January of 2008 and his death in July 2009, Mena had been prescribed no less than 35 prescription drugs, including numerous antidepressants, pain killers, tranquilizers and muscle relaxers.

O’Meara details how these two men exemplify the ever-increasing numbers of young, seemingly healthy soldiers who survived the horrors of war only to return home to fight, and lose, their toughest battle. They are among a growing list of sudden deaths among military personnel, which many believe is due to sudden cardiac arrest brought on by the drug cocktails being prescribed. Fred Baughman Jr., MD, who has been researching these questionable deaths, believes that the few that are known are just the “tip of the iceberg.”

Kelly Patricia O’Meara is a book author and former award winning investigative reporter for the Washington Times, Insight Magazine. Prior to working as an investigative journalist, O’Meara spent sixteen years on Capitol Hill as a congressional staffer to four Members of Congress. She holds a B.S. in Political Science from the University of Maryland.

Read the full article here.

Read the previous article, Psychiatric Drugs & War: A Suicide Mission here.

Visit CCHR’s Psychiatric Drug Side Effects database, comprising summaries of all international drug regulatory warnings, studies, and more than 470,000 adverse reaction reports filed with the US FDA.

CCHR is a non-profit, non-political, non-religious mental health watchdog. Its mission is to eradicate abuses committed under the guise of mental health and enact patient and consumer protections. CCHR has helped to enact more than 150 laws protecting individuals from abusive or coercive mental health practices.







gI_98860_novus-lgoo2

Recent Reports State That 19 Million Americans Abuse Prescription Drugs; FDA and Novus Medical Detox Agree That Education is Needed


New Port Richey, FL (PRWEB) August 11, 2014

Reports from the Centers for Disease Control and Prevention (CDC) state that 46 Americans die every day from prescription drug overdose, which adds up to about 17,000 deaths annually. The reports also state that poisonings by drug overdose have tripled over the past 30 years. (1) Novus Medical Detox, one of the only Florida-based detox centers serving high-dosage drug abuse patients, states that the reason behind the high number of fatalities lies in inadequate drug education.

The Food and Drug Administration (FDA) carries this same belief, and has responded by implementing a new drug education program. The program seeks to educate doctors who prescribe these highly-addictive painkillers, as well as the patients who are taking them. The program’s mission is “to teach doctors about proper opiate prescribing for pain patients to minimize the risks of diversion and addiction.” (4)

The United Nation’s World Drug Report 2014 stated that in 2012, 6.1% (19 million) of Americans abused prescription opioids, including morphine, codeine, OxyContin and Vicodin. This figure categorizes the United States as a country that abuses prescription drugs more than any other country in the world. (2) In an effort to lower the number of people harmed by these drugs, Novus warns Americans to exercise caution when receiving a new prescription from a physician, and to ask questions related to its side effects.

“Intentionally or not, Americans may be underestimating the highly addictive nature of drugs such as opioids,” stated Novus Executive Director Kent Runyon. “It may start as nothing more than filling a prescription for legitimate pain, but overdose may result when a patient seeks to elicit a stronger high from these drugs.”

Novus recommends that the following steps be taken when being prescribed a new medication (3):

●    Be sure that the prescription comes from a trusted physician;

●    Only use the medication as prescribed;

●    Ask the physician about the medicine and its effects;

●    Conduct your own research about the drug’s effects; and

●    Be prepared—ask your doctor what to do if one becomes addicted.

All of these tips are important to heed before a patient starts to take a medication, because addiction may begin with the patient being unaware of a medication’s initial effects. This patient may begin to take pills more liberally than prescribed, and the dangers of addiction do not lie far behind.

Runyon maintains that comprehensive drug education, starting in grade school and continuing throughout adult life to physician visits, can help to significantly reduce the number of Americans addicted to such drugs.

While new preventative measures are being taken, Novus recommends looking out for the following symptoms or behaviors (but not limited to), if someone suspects that a loved one is abusing pain reliever prescription drugs (5):

●    Nausea, drowsiness;

●    Mood swings and anxiety;

●    Slowed reactions, movement and breathing;

●    Jittery or secretive; and/or

●    Neglect of work/school responsibilities.

Runyon advises those who are dependent upon any abusive substance(s) to seek out safe, medically-supervised detox programs, and to use those with integrated medicine that allows the detox process to be as comfortable as possible.

For more information on Novus Medical Detox’s addiction and detox programs, visit http://www.NovusDetox.com.

About Novus Medical Detox Center:

Novus Medical Detox Center offers safe, effective alcohol and drug treatment programs in a home-like residential setting. Located on 3.25 tree-lined acres in New Port Richey, Fla., Novus is licensed by the Florida Department of Children and Families as an inpatient medical detox facility. Novus is known for minimizing the discomfort of withdrawal from prescription medication, drugs or alcohol by creating a customized detox program for each patient, incorporating medication, natural supplements and fluid replenishment—putting the dignity and humanity back into drug detoxification. Patients have 24/7 medical supervision, including round-the-clock nursing care and access to a withdrawal specialist, and enjoy comfortable private or shared rooms with a telephone, cable television, and high-speed Internet access. For more information, visit http://www.novusdetox.com.

1.Hutchins, Sarah. “Drug Overdose: Prescription Painkillers Poison 46 Americans Every Day.” Liberty Voice, 20 July 2014. Web. 22 July 2014. guardianlv.com/2014/07/drug-overdose-prescription-painkillers-poison-46-americans-every-day/.

2.Blake, Matthew. “Extent of US Dependency on Prescription Drugs Revealed: UN Report Shows 6% of American Adults Hooked on Pills.” Mail Online. Associated Newspapers, 07 July 2014. Web. 21 July 2014. dailymail.co.uk/news/article-2683318/Extent-US-dependency-prescription-drugs-revealed-UN-report-shows-6-American-adults-hooked-pills.html.

3.Winkel, Bethany. “Avoiding Prescription Drug Abuse—Treatment Solutions.” Treatment Solutions. N.p., 11 Feb. 2010. Web. 23 July 2014. treatmentsolutions.com/avoiding-prescription-drug-abuse/.

4.Sack, David. “FDA Prescription Drug Abuse Plan Hits—and Misses—the Mark—Addiction Recovery.” Addiction Recovery with David Sack, M.D. Psych Central.com, 7 July 2014. Web. 22 July 2014. blogs.psychcentral.com/addiction-recovery/2014/07/fda-prescription-drug-abuse-plan-hits-and-misses-the-mark/.

5.“Signs and Symptoms of Prescription Pain Reliever Abuse.” Narconon International, n.d. Web. 22 July 2014. narconon.org/drug-abuse/signs-symptoms-pain-relievers.html.







Marketresearchreports.biz: United States Anesthesia Drugs Market to Exceed US$3 Billion by 2018

Albany, NY (PRWEB) January 02, 2015

The 74-page report contains 56 figures and 1 table to aid comprehensive and insightful coverage of the market conditions.

Anesthesia drugs are widely used in surgeries, on a variable scale, to inhibit the senses of the patient. For minor surgeries only the body part being operated upon is treated with anesthesia drugs, numbing the nervous system in the particular area, whereas the patient is made completely unconscious for major surgeries.

View Full Report at http://www.marketresearchreports.biz/analysis/235624

The report counts the increasing population of geriatrics and the increasing prevalence of cardiac diseases as the prime drivers of the American anesthesia drugs market. The increasing number of cardiac surgeries drives up the demand for general anesthesia drugs, i.e., drugs that make the patient completely unconscious. Various other surgeries require local anesthesia drugs, which only numb and restrict the sensation in a particular area of the body. Surgeries performed on geriatric patients widely utilize anesthesia drugs, and the rising standard of healthcare in the United States is resulting in an increasing population of geriatrics. A general increase in the demand for anesthesia drugs is also observed from most medical fields.

Download Detail Report With Complete TOC at http://www.marketresearchreports.biz/sample/sample/235624

A shortage of anesthesia drug providers, both general and local, is the main restraint on the United States anesthesia drugs market. Supply chain networks exist in many locations, but they are not yet sufficiently integrated to form a strong nationwide supply network. This shortcoming is complemented by a shortage of anesthesia drugs in the United States. These two remain the major restraints for the United States anesthesia drugs market.

The anesthesia drugs market in the U.S.A. is segmented by the type of anesthesia drugs used: general or local. The market of general anesthesia drugs is further divided into two categories: inhaled and intravenous general anesthesia drugs. The latter, intravenous general anesthesia drugs, is the dominant category in the United States anesthesia drugs market. General anesthesia drugs are vital during major surgeries.

Special attention is provided to eight majorly used drugs in the category of general intravenous anesthesia drugs: Propofol, Fospropofol disodium, Ketamine, Pentobarbital, Methohexital sodium, Fentanyl, Etomidate, and Benzodiazepine class of drugs. The Benzodiazepine class drugs, Diazepam and Midazolam, are the dominant type of general intravenous anesthesia drugs.

Explore All Pharmaceutical Market Research Reports at http://www.marketresearchreports.biz/category/38

Similarly, the markets of five types of local anesthesia drugs are closely examined: Articaine, Bupivacaine, Lidocaine, Mepicavacaine, and Prilocaine. Lidocaine is the dominant local anesthesia drug.

The position and performance of major players in the American anesthesia drugs market are also analyzed. Three companies, namely Baxter International Inc., Endo Health Solutions, and Abbott Laboratories hold the majority share in the anesthesia drugs market. AstraZeneca is among the largest of the other players in the market.

Related Reports

Continuous Glucose Monitoring Market (Guardian Real Time, FreeStyle Navigator, Dexcom Seven Plus, Dexcom G4 Platinum, MiniMed Paradigm Revel/Veo CGM Systems And Others) – Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 – 2019

View Full Report at http://www.marketresearchreports.biz/analysis/168198

This report studies the current scenario as well as the future market potential for continuous glucose monitoring systems (CGMS) globally. The market for these CGMS has been segmented by major devices/brands, namely, Guardian Real Time CGM System, FreeStyle Navigator, Dexcom Seven Plus CGM System, Dexcom G4 Platinum, MiniMed Paradigm Revel/Veo System and others. The market for these systems has been extensively analyzed on the basis of factors such as their commercial launch, sales revenue, geographic presence, usage and technological developments. The market size and forecasts in terms of revenue (USD million) for each of these segments have been provided for the period 2011 to 2019, considering 2012 as the base year. The report also provides the compounded annual growth rate (CAGR) for each segment for the forecast period 2013 to 2019.

Download Detail Report With Complete TOC at http://www.marketresearchreports.biz/sample/sample/168198

The continuous glucose monitoring market has been classified into four segments namely, North America, Europe, Asia-Pacific and Rest of the World (RoW). The market size and forecast for each region has been provided for the period 2011 to 2019 along with the CAGR (%) for the forecast period 2013 to 2019. The study also includes qualitative analysis of the competitive scenario in these regions. The market overview section of the report comprises qualitative analysis of the overall market considering the factors determining the market dynamics such as drivers, restraints and opportunities, along with Porter’s five force analysis and market attractiveness analysis.

Organic Personal Care Products Market for Skin Care, Hair Care, Oral Care and Cosmetics – Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2012 – 2018

View Full Report at http://www.marketresearchreports.biz/analysis/170133

Organic personal care products market is growing at rapid pace across the world. Rising concerns for health safety, increasing green consciousness and growing consumer’s awareness about the hazards in synthetic chemicals have fueled the demand for organic personal care products. The study provides a strategic analysis of the global market for organic personal care products, and growth forecast for the period from 2012 to 2018. The study strives to compile together a broad view of the characteristics of organic personal care products market by providing historical data from 2011 and a forecast of up to 2018 along with detailed analyses in terms of revenues.

Download Detail Report With Complete TOC at http://www.marketresearchreports.biz/sample/sample/170133

The study provides the analysis of the market on a global as well as on regional level. The global economies included in the study are North America, Europe, Asia Pacific and Rest of the world (RoW). The study also provides analysis for various countries such as U.S. Mexico, Canada, Germany, France, the U.K., Russia, Italy, Spain, Japan, China, India, South Korea, Thailand, and Brazil in terms of revenue forecasted up to 2018. The study on organic personal care products market is categorized by different product category which includes skin care, hair care, oral care, cosmetics and others.

About MarketResearchReports.biz

Marketresearchreports.biz is the most comprehensive collection of market research reports, supporting clients’ market intelligence needs with over 100,000 market research reports, company profiles, data books, and regional market profits in its repository. We also offer consulting support for custom market research needs.

Our document database is updated by the hour, which means that our customers always have access to fresh data spanning over 300 industries. From Fortune 500 companies to SMEs, Marketresearchreports.biz has built a veritable reputation for fulfilling the most exacting market research needs.

Contact:

Sheela AK

State Tower

90 State Street,

Suite 700, Albany

NY 12207, United States

Toll Free: 866-997-4948

Email: sales(at)marketresearchreports(dot)biz







gI_129837_REdmond_smaller

Fulton County Government sues multiple drug companies for supplying and distributing prescription drugs in GA at the alleged disregard of state laws and citizen’s welfare


Atlanta, Georgia (PRWEB) April 06, 2015

A conglomerate of companies supplying and distributing prescription drugs in Fulton County and throughout the state of Georgia under the brand name of Cardinal Health Companies, McKesson Corporation and AmeriSourceBergen Drug Corporation are being sued by Fulton County for allegedly causing injuries and engaging in a course of conduct that violates Georgia law. The law suit was filed by Fulton County Government in the Superior Court of Fulton County on Wednesday, March 10, 2015 – Case No. 2015CV258133.

According to court documents, the civil action addresses the epidemic of prescription opioid drug abuse and addiction in the State of Georgia and the related costs to the County. According to the Center for Disease Control and Prevention (CDCP), more than 16,500 people died in 2010 in the United States from opioid painkillers, more than from heroin and cocaine combined, and prescription painkillers are now the nation’s number one drug problem.

The prescription drug distribution system is a sprawling one that involves approximately 800 companies that sell billions of pills annually as stated in the complaint presented to the court. In 2012, sales of prescription painkillers in the United States reached $ 8.5 billion according to industry reports according to court documents..

The Georgia Bureau of Investigation (GBI) has reported that of the 686 drug overdose deaths in 2012, 592 (86%) were prescription drugs. The annual cost to Fulton County from the abuse of prescription drug is estimated to be millions of dollars. These costs are from expenses for Fulton County’s hospitals and health agencies, courts, social service agencies, jails and prisons, etc. according to court documents.

According to further court documents,. Cardinal had sent 2,050,000 oxycodone pills to one store in Florida where the population in the town was 53,000. These defendants have supplied controlled substances to rogue drugstores and clinics which disburse controlled substances based on bogus prescriptions from physicians who are prescribing for illegitimate purposes.as stated in court documents.

The complaint found in court documents alleges that Defendants violated provisions within the Georgia Controlled Substances Act and the Georgia Pharmacy Practice Act. It alleges that Defendants have, by their acts and omissions, caused and substantially contributed to damages to Fulton County by violating Georgia law, by creating conditions which contribute to the violations of Georgia laws by others, and by their negligent and/or reckless disregard of the customs, standards and practices within their own industry.

This civil action has requested that the Court issue a temporary and permanent injunction which will mandate the defendants to inform the Georgia State Board of Pharmacy of all suspicious orders for controlled substances; direct the defendants to submit their system of determining suspicious drug orders; and enjoin defendants from distributing in Georgia any controlled substance for illegitimate medical purpose. The plaintiff, Fulton County, also asks to recover costs, losses and damages; reimbursement for litigation costs; and a trial by jury.

The lawsuit was filed on behalf of Fulton County by Attorneys Roderick Edmond of Edmond, Lindsay and Hoffler, LLP in Atlanta, Georgia and Mark Tate of the Tate Law Group in Savannah, Georgia. Mr. Tate says, “This litigation gives Fulton County the opportunity to force the Defendants who have profited handsomely on the ticket of Fulton County taxpayers to shift the burden of costs to where it should be.” Mr. Edmond commented that, “This is a statewide problem, and Fulton County had to take action to stem the tide of its financial losses from the prescription drug abuse epidemic.”







gI_97286_andrew-white4

Two Soldiers Prescribed 54 Drugs: Military Mental Health “Treatment” Becomes Frankenpharmacy


Los Angeles, California (PRWEB) October 31, 2012

By Kelly Patricia O’Meara, for the Citizens Commission on Human Rights (CCHR)

“The devastating adverse effects mind-altering psychiatric drugs may be having on the nation’s military troops are best summed up by Mary Shelley’s Dr. Frankenstein, writing ‘nothing is so painful to the human mind as a great and sudden change.’

“Just as the fictional character, Dr. Frankenstein, turned to experiments in the laboratory to create life with fantastically horrific results, the psychiatric community, along with its pharmaceutical sidekicks, has turned to modern day chemical concoctions to alter the human mind. The result is what many believe is a growing number of equally hideous results culminating in senseless deaths, tormented lives and grief-stricken families.

“The nation’s military troops are taking their lives at record numbers and seemingly healthy soldiers are dying from sudden unexplained deaths. That’s a fact. The data are clear, yet, despite growing evidence pointing to the enemy among us, the monstrous psycho-pharmacological experiment continues.”

In the second installment of a four-part series, O’Meara examines the sudden unexplained deaths within the military tied to psychiatric drug use, including two soldiers who between them, were prescribed a whopping 54 drugs including Seroquel, Effexor, Paxil, Prozac, Remeron, Wellbutrin, Xanax, Zoloft, Ativan, Celexa, Cymbalta, Depakote, Haldol, Klonopin, Lexapro, Lithium, Lunesta, Compazine, Desyrel, Trileptal and Valium.


Marine corporal Andrew White, was a healthy 23-year-old, gung-ho Marine returning from a nine-month tour in Iraq, who, like so many of his brothers in arms, suffered from the seemingly normal stresses of war – insomnia, nightmares and restlessness. The young corporal turned to the military’s mental health system for help. But eleven months after beginning his first cocktail of mind-altering psychiatric drugs, he died in his sleep from what the medical examiner ruled an “accidental overdose of medication.” Since taking his first multi-drug cocktail to the date of his death, White had been prescribed no less than nineteen different drugs with many at ever-increasing dosages.

Twenty-three -year old Anthony (Tony) Mena had completed two tours in Iraq as part of Kirtland Air Force Base’s 377th Security Forces Squadron. Like so many others returning from combat, Mena suffered from insomnia, restlessness and nightmares—and like Andrew White, became a victim of the military’s mental health mind-altering multi-drug approach to treatment. Between January of 2008 and his death in July 2009, Mena had been prescribed no less than 35 prescription drugs, including numerous antidepressants, pain killers, tranquilizers and muscle relaxers.

O’Meara details how these two men exemplify the ever-increasing numbers of young, seemingly healthy soldiers who survived the horrors of war only to return home to fight, and lose, their toughest battle. They are among a growing list of sudden deaths among military personnel, which many believe is due to sudden cardiac arrest brought on by the drug cocktails being prescribed. Fred Baughman Jr., MD, who has been researching these questionable deaths, believes that the few that are known are just the “tip of the iceberg.”

Kelly Patricia O’Meara is a book author and former award winning investigative reporter for the Washington Times, Insight Magazine. Prior to working as an investigative journalist, O’Meara spent sixteen years on Capitol Hill as a congressional staffer to four Members of Congress. She holds a B.S. in Political Science from the University of Maryland.

Read the full article here.

Read the previous article, Psychiatric Drugs & War: A Suicide Mission here.

Visit CCHR’s Psychiatric Drug Side Effects database, comprising summaries of all international drug regulatory warnings, studies, and more than 470,000 adverse reaction reports filed with the US FDA.

CCHR is a non-profit, non-political, non-religious mental health watchdog. Its mission is to eradicate abuses committed under the guise of mental health and enact patient and consumer protections. CCHR has helped to enact more than 150 laws protecting individuals from abusive or coercive mental health practices.







gI_98860_novus-lgoo

Recent Reports State That 19 Million Americans Abuse Prescription Drugs; FDA and Novus Medical Detox Agree That Education is Needed


New Port Richey, FL (PRWEB) August 11, 2014

Reports from the Centers for Disease Control and Prevention (CDC) state that 46 Americans die every day from prescription drug overdose, which adds up to about 17,000 deaths annually. The reports also state that poisonings by drug overdose have tripled over the past 30 years. (1) Novus Medical Detox, one of the only Florida-based detox centers serving high-dosage drug abuse patients, states that the reason behind the high number of fatalities lies in inadequate drug education.

The Food and Drug Administration (FDA) carries this same belief, and has responded by implementing a new drug education program. The program seeks to educate doctors who prescribe these highly-addictive painkillers, as well as the patients who are taking them. The program’s mission is “to teach doctors about proper opiate prescribing for pain patients to minimize the risks of diversion and addiction.” (4)

The United Nation’s World Drug Report 2014 stated that in 2012, 6.1% (19 million) of Americans abused prescription opioids, including morphine, codeine, OxyContin and Vicodin. This figure categorizes the United States as a country that abuses prescription drugs more than any other country in the world. (2) In an effort to lower the number of people harmed by these drugs, Novus warns Americans to exercise caution when receiving a new prescription from a physician, and to ask questions related to its side effects.

“Intentionally or not, Americans may be underestimating the highly addictive nature of drugs such as opioids,” stated Novus Executive Director Kent Runyon. “It may start as nothing more than filling a prescription for legitimate pain, but overdose may result when a patient seeks to elicit a stronger high from these drugs.”

Novus recommends that the following steps be taken when being prescribed a new medication (3):

●    Be sure that the prescription comes from a trusted physician;

●    Only use the medication as prescribed;

●    Ask the physician about the medicine and its effects;

●    Conduct your own research about the drug’s effects; and

●    Be prepared—ask your doctor what to do if one becomes addicted.

All of these tips are important to heed before a patient starts to take a medication, because addiction may begin with the patient being unaware of a medication’s initial effects. This patient may begin to take pills more liberally than prescribed, and the dangers of addiction do not lie far behind.

Runyon maintains that comprehensive drug education, starting in grade school and continuing throughout adult life to physician visits, can help to significantly reduce the number of Americans addicted to such drugs.

While new preventative measures are being taken, Novus recommends looking out for the following symptoms or behaviors (but not limited to), if someone suspects that a loved one is abusing pain reliever prescription drugs (5):

●    Nausea, drowsiness;

●    Mood swings and anxiety;

●    Slowed reactions, movement and breathing;

●    Jittery or secretive; and/or

●    Neglect of work/school responsibilities.

Runyon advises those who are dependent upon any abusive substance(s) to seek out safe, medically-supervised detox programs, and to use those with integrated medicine that allows the detox process to be as comfortable as possible.

For more information on Novus Medical Detox’s addiction and detox programs, visit http://www.NovusDetox.com.

About Novus Medical Detox Center:

Novus Medical Detox Center offers safe, effective alcohol and drug treatment programs in a home-like residential setting. Located on 3.25 tree-lined acres in New Port Richey, Fla., Novus is licensed by the Florida Department of Children and Families as an inpatient medical detox facility. Novus is known for minimizing the discomfort of withdrawal from prescription medication, drugs or alcohol by creating a customized detox program for each patient, incorporating medication, natural supplements and fluid replenishment—putting the dignity and humanity back into drug detoxification. Patients have 24/7 medical supervision, including round-the-clock nursing care and access to a withdrawal specialist, and enjoy comfortable private or shared rooms with a telephone, cable television, and high-speed Internet access. For more information, visit http://www.novusdetox.com.

1.Hutchins, Sarah. “Drug Overdose: Prescription Painkillers Poison 46 Americans Every Day.” Liberty Voice, 20 July 2014. Web. 22 July 2014. guardianlv.com/2014/07/drug-overdose-prescription-painkillers-poison-46-americans-every-day/.

2.Blake, Matthew. “Extent of US Dependency on Prescription Drugs Revealed: UN Report Shows 6% of American Adults Hooked on Pills.” Mail Online. Associated Newspapers, 07 July 2014. Web. 21 July 2014. dailymail.co.uk/news/article-2683318/Extent-US-dependency-prescription-drugs-revealed-UN-report-shows-6-American-adults-hooked-pills.html.

3.Winkel, Bethany. “Avoiding Prescription Drug Abuse—Treatment Solutions.” Treatment Solutions. N.p., 11 Feb. 2010. Web. 23 July 2014. treatmentsolutions.com/avoiding-prescription-drug-abuse/.

4.Sack, David. “FDA Prescription Drug Abuse Plan Hits—and Misses—the Mark—Addiction Recovery.” Addiction Recovery with David Sack, M.D. Psych Central.com, 7 July 2014. Web. 22 July 2014. blogs.psychcentral.com/addiction-recovery/2014/07/fda-prescription-drug-abuse-plan-hits-and-misses-the-mark/.

5.“Signs and Symptoms of Prescription Pain Reliever Abuse.” Narconon International, n.d. Web. 22 July 2014. narconon.org/drug-abuse/signs-symptoms-pain-relievers.html.







Marketresearchreports.biz: United States Anesthesia Drugs Market to Exceed US$3 Billion by 2018

Albany, NY (PRWEB) January 02, 2015

The 74-page report contains 56 figures and 1 table to aid comprehensive and insightful coverage of the market conditions.

Anesthesia drugs are widely used in surgeries, on a variable scale, to inhibit the senses of the patient. For minor surgeries only the body part being operated upon is treated with anesthesia drugs, numbing the nervous system in the particular area, whereas the patient is made completely unconscious for major surgeries.

View Full Report at http://www.marketresearchreports.biz/analysis/235624

The report counts the increasing population of geriatrics and the increasing prevalence of cardiac diseases as the prime drivers of the American anesthesia drugs market. The increasing number of cardiac surgeries drives up the demand for general anesthesia drugs, i.e., drugs that make the patient completely unconscious. Various other surgeries require local anesthesia drugs, which only numb and restrict the sensation in a particular area of the body. Surgeries performed on geriatric patients widely utilize anesthesia drugs, and the rising standard of healthcare in the United States is resulting in an increasing population of geriatrics. A general increase in the demand for anesthesia drugs is also observed from most medical fields.

Download Detail Report With Complete TOC at http://www.marketresearchreports.biz/sample/sample/235624

A shortage of anesthesia drug providers, both general and local, is the main restraint on the United States anesthesia drugs market. Supply chain networks exist in many locations, but they are not yet sufficiently integrated to form a strong nationwide supply network. This shortcoming is complemented by a shortage of anesthesia drugs in the United States. These two remain the major restraints for the United States anesthesia drugs market.

The anesthesia drugs market in the U.S.A. is segmented by the type of anesthesia drugs used: general or local. The market of general anesthesia drugs is further divided into two categories: inhaled and intravenous general anesthesia drugs. The latter, intravenous general anesthesia drugs, is the dominant category in the United States anesthesia drugs market. General anesthesia drugs are vital during major surgeries.

Special attention is provided to eight majorly used drugs in the category of general intravenous anesthesia drugs: Propofol, Fospropofol disodium, Ketamine, Pentobarbital, Methohexital sodium, Fentanyl, Etomidate, and Benzodiazepine class of drugs. The Benzodiazepine class drugs, Diazepam and Midazolam, are the dominant type of general intravenous anesthesia drugs.

Explore All Pharmaceutical Market Research Reports at http://www.marketresearchreports.biz/category/38

Similarly, the markets of five types of local anesthesia drugs are closely examined: Articaine, Bupivacaine, Lidocaine, Mepicavacaine, and Prilocaine. Lidocaine is the dominant local anesthesia drug.

The position and performance of major players in the American anesthesia drugs market are also analyzed. Three companies, namely Baxter International Inc., Endo Health Solutions, and Abbott Laboratories hold the majority share in the anesthesia drugs market. AstraZeneca is among the largest of the other players in the market.

Related Reports

Continuous Glucose Monitoring Market (Guardian Real Time, FreeStyle Navigator, Dexcom Seven Plus, Dexcom G4 Platinum, MiniMed Paradigm Revel/Veo CGM Systems And Others) – Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 – 2019

View Full Report at http://www.marketresearchreports.biz/analysis/168198

This report studies the current scenario as well as the future market potential for continuous glucose monitoring systems (CGMS) globally. The market for these CGMS has been segmented by major devices/brands, namely, Guardian Real Time CGM System, FreeStyle Navigator, Dexcom Seven Plus CGM System, Dexcom G4 Platinum, MiniMed Paradigm Revel/Veo System and others. The market for these systems has been extensively analyzed on the basis of factors such as their commercial launch, sales revenue, geographic presence, usage and technological developments. The market size and forecasts in terms of revenue (USD million) for each of these segments have been provided for the period 2011 to 2019, considering 2012 as the base year. The report also provides the compounded annual growth rate (CAGR) for each segment for the forecast period 2013 to 2019.

Download Detail Report With Complete TOC at http://www.marketresearchreports.biz/sample/sample/168198

The continuous glucose monitoring market has been classified into four segments namely, North America, Europe, Asia-Pacific and Rest of the World (RoW). The market size and forecast for each region has been provided for the period 2011 to 2019 along with the CAGR (%) for the forecast period 2013 to 2019. The study also includes qualitative analysis of the competitive scenario in these regions. The market overview section of the report comprises qualitative analysis of the overall market considering the factors determining the market dynamics such as drivers, restraints and opportunities, along with Porter’s five force analysis and market attractiveness analysis.

Organic Personal Care Products Market for Skin Care, Hair Care, Oral Care and Cosmetics – Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2012 – 2018

View Full Report at http://www.marketresearchreports.biz/analysis/170133

Organic personal care products market is growing at rapid pace across the world. Rising concerns for health safety, increasing green consciousness and growing consumer’s awareness about the hazards in synthetic chemicals have fueled the demand for organic personal care products. The study provides a strategic analysis of the global market for organic personal care products, and growth forecast for the period from 2012 to 2018. The study strives to compile together a broad view of the characteristics of organic personal care products market by providing historical data from 2011 and a forecast of up to 2018 along with detailed analyses in terms of revenues.

Download Detail Report With Complete TOC at http://www.marketresearchreports.biz/sample/sample/170133

The study provides the analysis of the market on a global as well as on regional level. The global economies included in the study are North America, Europe, Asia Pacific and Rest of the world (RoW). The study also provides analysis for various countries such as U.S. Mexico, Canada, Germany, France, the U.K., Russia, Italy, Spain, Japan, China, India, South Korea, Thailand, and Brazil in terms of revenue forecasted up to 2018. The study on organic personal care products market is categorized by different product category which includes skin care, hair care, oral care, cosmetics and others.

About MarketResearchReports.biz

Marketresearchreports.biz is the most comprehensive collection of market research reports, supporting clients’ market intelligence needs with over 100,000 market research reports, company profiles, data books, and regional market profits in its repository. We also offer consulting support for custom market research needs.

Our document database is updated by the hour, which means that our customers always have access to fresh data spanning over 300 industries. From Fortune 500 companies to SMEs, Marketresearchreports.biz has built a veritable reputation for fulfilling the most exacting market research needs.

Contact:

Sheela AK

State Tower

90 State Street,

Suite 700, Albany

NY 12207, United States

Toll Free: 866-997-4948

Email: sales(at)marketresearchreports(dot)biz